Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and Hypertension

NCT06256172 is registered in ClinicalTrials.gov with Olawuyi Racett Nigeria Ltd as lead sponsor.

NCT NCT06256172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06256172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and Hypertension
Lead sponsor
Olawuyi Racett Nigeria Ltd
Phase
Not applicable
Overall status
Completed
Start date
June 16, 2023
Completion date
December 16, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, congestive heart failure, diabetes mellitus, hypertension, myasthenia gravis